Related Experiment Video
Updated: Aug 21, 2026

Experimental Analysis of Apoptotic Thymocyte Engulfment by Macrophages
Published on: May 24, 2019
The glucocorticoid-induced gene tdag8 encodes a pro-apoptotic G protein-coupled receptor whose activation promotes
Michael H Malone1, Zhengqi Wang, Clark W Distelhorst
1Department of Medicine, Comprehensive Cancer Center, Case Western Reserve University School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106, USA.
Abstract:
The apoptotic action of glucocorticoids on lymphocytes makes them effective therapeutics for many lymphoid malignancies. Although it is clear that glucocorticoid-induced apoptosis requires transcription, the gene products that induce apoptosis remain unknown. Using gene expression profiles of lymphoma cell lines and primary thymocytes treated with the synthetic glucocorticoid dexamethasone, we discovered that induction of tdag8 (T-cell death-associated gene 8) was a common event in each model system investigated. Activation of TDAG8 by its agonist psychosine markedly enhanced dexamethasone-induced apoptosis in a TDAG8-dependent manner. Expression of a TDAG8-GFP fusion protein was sufficient to induce apoptosis, and repression of endogenous TDAG8 using RNA interference partially inhibited dexamethasone-induced apoptosis. Together, these data suggest that TDAG8 is a regulator of glucocorticoid-induced apoptosis and that agonists of TDAG8 may be promising agents to improve the efficacy of glucocorticoids for the treatment of leukemia and lymphoma.
Insights
Glucocorticoids induce lymphocyte apoptosis, crucial for treating lymphoid cancers. Researchers identified T-cell death-associated gene 8 (TDAG8) as a key mediator, suggesting TDAG8 agonists could enhance cancer therapy.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Glucocorticoids are vital for treating lymphoid malignancies due to their apoptotic effects on lymphocytes.
- The specific gene products mediating glucocorticoid-induced apoptosis remain largely unidentified.
- Understanding these mechanisms is critical for improving cancer therapeutics.
Purpose of the Study:
- To identify novel gene products involved in glucocorticoid-induced apoptosis in lymphoid cells.
- To investigate the role of T-cell death-associated gene 8 (TDAG8) in this process.
- To explore the therapeutic potential of targeting TDAG8 for lymphoid malignancies.
Main Methods:
- Gene expression profiling of lymphoma cell lines and thymocytes treated with dexamethasone.
- Investigating the effect of TDAG8 activation by its agonist, psychosine.
- Utilizing TDAG8-GFP fusion protein expression and RNA interference to modulate TDAG8 levels.
Main Results:
- T-cell death-associated gene 8 (TDAG8) induction was consistently observed following dexamethasone treatment.
- Activation of TDAG8 significantly enhanced dexamethasone-induced apoptosis in a TDAG8-dependent manner.
- Overexpression of TDAG8 induced apoptosis, while its repression partially inhibited dexamethasone-induced apoptosis.
Conclusions:
- TDAG8 acts as a key regulator in glucocorticoid-induced apoptosis of lymphocytes.
- TDAG8 agonists show promise as a strategy to augment glucocorticoid efficacy in treating leukemia and lymphoma.
- Targeting TDAG8 represents a potential novel therapeutic avenue for lymphoid cancers.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
07:17Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Related Concept Videos
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Caspases
GPCR Desensitization
Apoptosis